FDA Introduces ‘Proactive‘ Resilient Supply Chain Program To Reduce Future Device Shortages
Executive Summary
The US FDA’s Resilient Supply Chain Program (RSCP) will be housed in the agency’s Office of Strategic Partnerships and Technology Innovation and aims to reduce future supply chain shortages by applying lessons learned during the pandemic.
You may also be interested in...
Some Essential Cardiac Devices In Short Supply, FDA Warns
The US Food and Drug Administration is alerting health care providers that some cardiac devices from a major supplier are in short supply.
FDA Should Undo Incentives For Single-Use Products, Device Reprocessing Expert Says
Medtech Insight sat down with Dan Vukelich, president and CEO of the Association of Medical Device Reprocessors, to discuss the need for sustainable alternatives to limit waste from medical devices.
FDA Needs To Undo Incentives For Single-Use Products, Device Reprocessing Expert Says
Medtech Insight sat down with Dan Vukelich, president and CEO of the Association of Medical Device Reprocessors, to discuss the need for sustainable alternatives to limit waste from medical devices.